Alternate Day Buprenorphine Administration, Phase XII - 17

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to determine if six times daily buprenorphine dose is effective in achieving 120 hour buprenorphine dosing.

Key facts

Study ID

NCT00000235

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Last updated by the study team

2005-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.